Search results
How To Know If Marinus Pharmaceuticals Inc
Marketing Sentinel· 6 days agoIn last trading session, Marinus Pharmaceuticals Inc (NASDAQ:MRNS) saw 1.52 million shares changing hands with its beta currently measuring 1.08. Company’s recent per share ...
Corcept (CORT) Rises as Cushing's Syndrome Study Meets Goal
Zacks via Yahoo Finance· 13 hours agoCorcept's (CORT) phase III GRACE study, evaluating its lead candidate, relacorilant, for treating...
Insmed (INSM) Stock Soars 118% on Upbeat Lung Disease Drug Data
Zacks via Yahoo Finance· 12 hours agoData from a late-stage study shows that treatment with Insmed's (INSM) brensocatib reduced episodes...
Marinus Pharmaceuticals Inc [NASDAQ: MRNS] Sees Increase in Stock Value – Knox Daily
Knox Daily· 6 days agoAs published in a research note from Robert W. Baird on April 16, 2024, Marinus Pharmaceuticals Inc [MRNS] has been rated down from an Outperform to a Neutral and the price ...
Mirum's (MIRM) Livmarli Aids Sales but Overdependence Concerns
Zacks via Yahoo Finance· 2 days agoMirum's (MIRM) lead drug, Livmarli, continues to generate steady sales. The recent label expansion...
Sanofi's (SNY) Sarclisa sBLA Gets FDA's Priority Review Tag
Zacks via Yahoo Finance· 3 days agoThe FDA grants priority review to Sanofi's (SNY) sBLA for the Sarclisa combination regimen for...
Puma Biotechnology (PBYI) Falls 38% in 3 Months: Here's Why
Zacks· 6 days agoSales of Puma Biotechnology's (PBYI) sole marketed drug, Nerlynx, have been declining in recent quarters. Stiff competition in the target market is also a woe.
Cartesian (RNAC) Up as FDA Grants RMAT Tag to Descartes-08
Zacks· 7 days agoFree Report) announced that the FDA has granted the Regenerative Medicine Advanced Therapy (RMAT) designation to its lead pipeline candidate, Descartes-08, for the treatment of myasthenia gravis ...
